Remediation of environmental toxicants using carbonaceous materials: opportunity and challenges.

Adsorption and photocatalytic properties of carbonaceous materials, viz., carbon nanotubes (CNTs), fullerene, graphene, graphene oxide, carbon nanofiber nanospheres, and activated carbon, are the legitimate weapons for the remediation of emerging and persistent inorganic/organic contaminants, heavy metals, and radionucleotides from the environment. High surface area, low or non-toxic nature, ease of synthesis, regeneration, and chemical modification of carbonaceous material make them ideal for the removal of toxicants. The research techniques investigated during the last decade for the elimination of environmental toxicants using carbonaceous materials are reviewed to offer comprehensive insight into the mechanism, efficiency, applications, advantages, and shortcomings. Opportunities and challenges associated with carbon materials have been discussed to suggest future perspectives in the remediation of environmental toxicants.

A comprehensive update on phytochemistry, analytical aspects, medicinal attributes, specifications and stability of stigmasterol.

Phytosterols are bioactive substances naturally found in plant cell membranes, and their chemical structure is comparable to cholesterol found in mammalian cells. They are widely distributed in plant foods like olive oil, nuts, seeds, and legumes. Amongst the variety of phytosterols, stigmasterol is the vital compound found abundantly in plants. Numerous hormones, including estrogen, progesterone, corticoids and androgen, are synthesized by stigmasterol. Multiple in-vitro and in-vivo investigations have shown that stigmasterol has various biological effects, including antioxidant, anticancer, antidiabetic, respiratory diseases, and lipid-lowering effects. Experimental research on stigmasterol provides indisputable proof that this phytosterol has the potential to be employed in supplements used to treat the illnesses mentioned above. This substance has a high potential, making it a noteworthy medication in the future. Although several researchers have investigated this phytosterol to assess its prospective qualities, it has not yet attained therapeutic levels, necessitating additional clinical studies. This review offers a comprehensive update on stigmasterol, including chemical framework, biosynthesis, synthetic derivatives, extraction and isolation, analytical aspects, pharmacological profile, patent status, clinical trials, stability and specifications as per regulatory bodies.